Launch week offerEnds in00h00m00s

annual Promonthly Pro

Giovanni Falcicchio

University of Bari Aldo Moro

Italy

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in Italy

Articles (20)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Collaborators (13)

Elisa Bianchi

Mario Negri Institute for pharmacological research

ITALY

View details

Laura Librizzi

senior researcher

Fondazione IRCCS Istituto Neurologico Carlo Besta

ITALY

View details

Payam Tabaee Damavandi

University of Milano-Bicocca

ITALY

View details

CHIARA PIZZANELLI

ITALY

View details

Maria Mariggiò

ITALY

View details

Simona Balestrini

Associate Professor of Child Neurology

University of Florence

ITALY

View details

Mariana Fernandes

University of Rome Tor Vergata

ITALY

View details

Umberto AGUGLIA

Professore Ordinario Neurologia

Università degli Studi Mediterranea di Reggio Calabria

ITALY

View details

Jacopo C. DiFrancesco

University of Milano-Bicocca

ITALY

View details

Anna Elisabetta Vaudano

University of Modena and Reggio Emilia

ITALY

View details

Massimo GANGITANO

University of Palermo

ITALY

View details

Cinzia Costa

University of Perugia

ITALY

View details

Francesco Fortunato

Ricercatori a tempo determinato

Magna Graecia University

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Giovanni Falcicchio

Research Interests

Make your next move.

Explore related searches

Articles (20)

Exploring the Potential Role of CYP2C19 Genetic Variability in Cenobamate Treatment

Early sedation-related adverse events with the cenobamate–clobazam combination in drug-resistant epilepsy: real-world preliminary observations

Lacosamide is Associated with a Higher Treatment Persistence at 12 Months than Brivaracetam and Perampanel Despite Similar Efficacy

Sudden unexpected death in epilepsy: An Italian expert consensus statement on risk, mechanisms, prevention, and therapeutic strategies

Beyond efficacy: defining the cenobamate response profile

Climate Change: A National Survey on Viewpoints of Italian Epilepsy‐Care Professionals

Pregnancy and epilepsy: pharmacokinetic insights into antiseizure medications

Etiological diagnosis of late‐onset epilepsy: A key priority for Italian epileptologists – Insights from a LICE survey

Adjunctive Brivaracetam in People with Epilepsy and Intellectual Disability: Evidence from the BRIVAracetam Add-On First Italian netwoRk Study

Efficacy and tolerability of low versus standard daily doses of antiseizure medications in newly diagnosed focal epilepsy. A multicenter, randomized, single‐blind, non‐inferiority trial (STANDLOW)

Effectiveness and safety of adjunctive cenobamate in people with focal-onset epilepsy: Interim results after 24-week observational period from the BLESS study

Cutaneous adverse reactions to low doses of cenobamate: don’t DRESS it up…tell the truth!

Dramatic response to delayed treatment with tocilizumab in new-onset refractory status epilepticus

Valproate discontinuation in girls and women of childbearing age with epilepsy: An Italian multicenter retrospective study on prescribing patterns and outcomes

Drug-induced liver injury during valproic acid and cenobamate coadministration: a direct consequence or an unforeseen event?

Early considerations about the safety of cenobamate in the treatment of status epilepticus

Adjunctive cenobamate in people with focal onset seizures: Insights from the Italian Expanded Access Program

Adjunctive brivaracetam and sustained seizure frequency reduction in very active focal epilepsy

A real‐world comparison among third‐generation antiseizure medications: Results from the <scp>COMPARE</scp> study

Cenobamate as add-on therapy for drug resistant epilepsies: effectiveness, drug to drug interactions and neuropsychological impact. What have we learned from real word evidence?

Collaborators (13)

Elisa Bianchi

Laura Librizzi

Payam Tabaee Damavandi

CHIARA PIZZANELLI

Maria Mariggiò

Simona Balestrini

Mariana Fernandes

Umberto AGUGLIA

Jacopo C. DiFrancesco

Anna Elisabetta Vaudano

Massimo GANGITANO

Cinzia Costa

Francesco Fortunato

Make your next move.